MNG162
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- ANGIOGENESIS+0.416
- MYC_TARGETS_V2+0.388
- EPITHELIAL_MESENCHYMAL_TRANSITION+0.361
- E2F_TARGETS+0.319
- G2M_CHECKPOINT+0.311
- HEDGEHOG_SIGNALING+0.308
- UNFOLDED_PROTEIN_RESPONSE+0.272
- NOTCH_SIGNALING+0.230
- REACTIVE_OXYGEN_SPECIES_PATHWAY+0.218
- GLYCOLYSIS+0.204
Top 10 suppressed
- TGF_BETA_SIGNALING-0.350
- HEME_METABOLISM-0.267
- ANDROGEN_RESPONSE-0.243
- BILE_ACID_METABOLISM-0.210
- UV_RESPONSE_DN-0.183
- XENOBIOTIC_METABOLISM-0.151
- KRAS_SIGNALING_UP-0.141
- ALLOGRAFT_REJECTION-0.135
- SPERMATOGENESIS-0.131
- COAGULATION-0.122
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | MNG883 | — | — | 0.761 |
| 2 | SRR15030851 | — | — | 0.736 |
| 3 | MNG163 | — | — | 0.727 |
| 4 | ULC0524T_S17 | — | cohortA1 | 0.717 |
| 5 | TCGA-46-6025-01A-11R-1820-07 | — | cohortSQ2 | 0.714 |
| 6 | SRR8518200 | — | E | 0.709 |
| 7 | MNG715 | — | — | 0.702 |
| 8 | TCGA-85-8276-01A-11R-2296-07 | — | cohortSQ1 | 0.698 |
| 9 | C3L-02127 | — | cohortSQ2 | 0.695 |
| 10 | TCGA-85-8288-01A-11R-2296-07 | — | cohortSQ1 | 0.685 |